Print

Celgene (CELG) (JOBS) Investors Struggle with Confusing Data  
12/9/2009 7:07:57 AM

Bookmark and Share

Reuters -- Celgene Corp (CELG.O) investors were struggling on Tuesday to sort through confusing results from a key trial of the company's cancer drug Revlimid.

//-->